Top 10 Stocks To Buy For 2019

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Try for free today and see what we’re talking about! Here is some more information if you’re curious.

Welcome to another edition of “3 Things In Biotech,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

Mallinckrodt’s jaundice drug rejected by the FDA

Company: Mallinckrodt (NYSE:MNK)

Therapy: Stannsoporfin

Disease: Severe jaundice

News: MNK announced that a joint advisory committee at the FDA has voted against the risk-benefit profile of its medication stannsoporfin, which was intended to prevent severe hemolysis in newborns who are at risk of severe jaundice. The company guided that it would seek FDA input on what further data might be required in order to get a positive vote in the future.

Looking forward: And so the stannsoporfin story ends…for now! At this time, this looks like a very expensive ($80 million) mistake on the part of MNK, but I think it’s reasonable to expect that it’ll be able to resolve the data issues that sunk this application. But that’s going to take some serious time, and you can probably put this one in the back of your mind for at least another year, I’d wager.

Top 10 Stocks To Buy For 2019: Coherus BioSciences, Inc.(CHRS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Coherus Biosciences (NASDAQ: CHRS) and Allena Pharmaceuticals (NASDAQ:ALNA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) gained nearly 49% last month, according to data provided by S&P Global Market Intelligence. The company announced a global settlement with AbbVie that will allow the small-cap biopharma to commercialize a biosimilar to Humira, which was developed as CHS-1420. The pair had previously sparred over patents related to formulating the antibody.

  • [By Maxx Chatsko]

    Shares of Coherus BioSciences (NASDAQ:CHRS) fell over 18% last month, according to data provided by S&P Global Market Intelligence.

    The biopharma stock erupted higher in July after Coherus announced that the Committee for Medicinal Products for Human Use (CHMP) — a European Union regulatory body that makes recommendations to the European Medicines Agency (EMA), which is the equivalent to the U.S. Food and Drug Administration — would reconsider the company’s application for a generic version of Neulasta (pegfilgrastim). That put it on track to getting its first commercial product on the market.

  • [By Stephan Byrd]

    Krystal Biotech (NASDAQ:KRYS) and Coherus Biosciences (NASDAQ:CHRS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, profitability, institutional ownership and dividends.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Coherus Biosciences (CHRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    The market isn’t warming up to Sohu.com’s (NASDAQ:SOHU) latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning. 

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They’re among the biggest losers through the first three quarters of 2018. Let’s go over why I think they have a shot at bouncing back in the next three months.

  • [By Rick Munarriz]

    It’s now been seven months since Sohu.com (NASDAQ:SOHU) completed its objective of spinning off Sogou. Sogou had been the fastest growing component at Sohu for years. It should have taken off after trading on its own merits, but that failed to happen. Though the shares inched slightly higher in their first few days of trading, Sogou has spent most of its time since late November as a broken IPO until it finally cracked the $13 ceiling today in intraday trading.

  • [By Anders Bylund]

    Sogou’s shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don’t feel connected to Sogou’s business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It’s a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu’s business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou’s largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock’s volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou’s third-quarter revenues by a significant but unannounced amount.

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

Top 10 Stocks To Buy For 2019: LGI Homes, Inc.(LGIH)

Advisors’ Opinion:

  • [By Tyler Crowe]

    This isn’t to say that investing in homebuilding is an awful idea — the trends mentioned above are incredibly strong indicators that investing in housing can pay off. What matters is you have to be incredibly discerning when selecting the business in which you want to invest. To me, there are only two stocks that are really worth exploring as potential investments: LGI Homes (NASDAQ:LGIH) and NVR Inc. (NYSE:NVR). Here’s why these two homebuilders stand out among the crowd.

  • [By ]

    LG Homes (LGIH) : “I like Lennar (LEN) and I also like Toll Brothers (TOL) .”

    GrubHub (GRUB) : “I’ve been riding this one for a long time. It might be time to take some profits. “

  • [By Neha Chamaria, Jason Hall, and Dan Caplinger]

    So, when we asked three of our Motley Fool contributors to each name a stock that has doubled and still has room to grow, they picked lululemon athletica (NASDAQ:LULU), LGI Homes Inc (NASDAQ:LGIH), and XPO Logistics (NYSE:XPO). Here’s why.

  • [By Shane Hupp]

    LGI Homes Inc (NASDAQ:LGIH) – Wedbush decreased their Q2 2019 earnings per share (EPS) estimates for shares of LGI Homes in a report released on Friday, July 6th. Wedbush analyst J. Mccanless now anticipates that the financial services provider will post earnings per share of $1.58 for the quarter, down from their previous forecast of $1.61. Wedbush has a “Neutral” rating and a $65.00 price objective on the stock. Wedbush also issued estimates for LGI Homes’ Q3 2019 earnings at $2.13 EPS and Q4 2019 earnings at $2.79 EPS.

Top 10 Stocks To Buy For 2019: T. Rowe Price Group, Inc.(TROW)

Advisors’ Opinion:

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was T. Rowe Price Group, Inc. (NASDAQ: TROW) which fell about 5% to $107.70. The stock’s 52-week range is $81.77 to $127.43. Volume was about 2.5 million compared to the daily average volume of 1.1 million.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on T. Rowe Price Group (TROW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Press coverage about T. Rowe Price (NASDAQ:TROW) has trended somewhat positive on Wednesday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. T. Rowe Price earned a news impact score of 0.20 on Accern’s scale. Accern also assigned media stories about the asset manager an impact score of 47.382716620203 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By ]

    T Rowe Price (Nasdaq: TROW) — It has been a tough stretch for many money managers, as investors siphon assets away from traditional mutual funds and deposit them in passive exchange-traded funds (ETFs). But T. Rowe Price bucked the trend and attracted $2.7 billion in net inflows last quarter, raising its assets under management (AUM) to $1.08 trillion.

  • [By Max Byerly]

    T. Rowe Price Group Inc (NASDAQ:TROW) Director Robert F. Maclellan sold 5,000 shares of T. Rowe Price Group stock in a transaction on Wednesday, May 30th. The shares were sold at an average price of $122.58, for a total value of $612,900.00. Following the completion of the transaction, the director now owns 13,769 shares in the company, valued at $1,687,804.02. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Top 10 Stocks To Buy For 2019: JA Solar Holdings, Co., Ltd.(JASO)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Bank of America Corp. (NYSE: BAC) leads a strong day of earnings reports on Wall Street. The commercial banking giant was expected to report earnings per share (EPS) of $0.57 on top of $22.4 billion in revenue. The company topped both numbers, including EPS of $0.63. The company said its performance was bolstered by stronger profit margins, the 2017 GOP tax plan, and higher revenue from banking fees. President Donald Trump will meet with Russian President Vladimir Putin in Helsinki, Finland. Trump could request that Russia assist with the denuclearization of North Korea during their summit. Trump has said that he expects that he and Putin will have an “extraordinary friendship” at the conclusion of the event. The meeting comes just days after the U.S. government announced 12 indictments against Russian officials on charges of conspiracy to interfere with the 2016 presidential election. Global growth is back in focus after China announced second-quarter GDP expectations. The government announced that Q2 GDP came in at 6.7% as the country has been cracking down on risky credit offerings. Markets are continually worried about China’s Shanghai Composite – which recently entered bear territory. The third quarter will be interesting for markets as trade tensions accelerate between the United States and China.
    Four Stocks to Watch Today: NFLX, AMZN, TWTR, CAT
    Shares of Netflix Inc. (Nasdaq: NFLX) are in focus as the company prepares to report earnings after the bell. Wall Street analysts project that the company will report EPS of $0.80 on top of $3.93 billion in revenue. Analysts will be paying close attention to whether the online-streaming giant has been able to continue to aggressively increase its international user base. Amazon.com Inc. (Nasdaq: AMZN) is generating buzz as the company prepares to kick-start its annual Prime Day. The annual shopping event will take place starting this evening and stretch through Tuesday. According to the website Reta

  • [By Travis Hoium]

    The impact will have ripple effects across the industry. Major manufacturers like Canadian Solar (NASDAQ:CSIQ), JinkoSolar (NYSE:JKS), Hanwha Q Cells (NASDAQ:HQCL), and JA Solar (NASDAQ:JASO) will see margins squeezed as volume and sales prices fall. They were all enjoying higher margins and strong demand in early 2018, so the could reverse to net losses later this year. 

  • [By Rich Smith]

    Fearing that prospects for the solar industry are dimming, yesterday analysts at Roth Capital bailed on the solar industry wholesale, downgrading shares of Hanwha Q Cells, JA Solar Holdings (NASDAQ:JASO), and ReneSola to sell. This morning, Merrill Lynch showed signs it’s planning to join the rush to the exits as well, downgrading American solar manufacturer First Solar (NASDAQ:FSLR) to neutral.

  • [By Garrett Baldwin]

    We’re about to reveal a little wealth secret that could unlock the trade of a lifetime. Money Morning Special Situation Strategist Tim Melvin takes you inside what could easily be a 10-bagger for investors in the weeks ahead. Read more right here.

    The Top Stock Market Stories for Tuesday
    The Euro has plunged to its lowest point against the U.S. dollar in 2018 thanks to political problems in Europe. The breakdown of power in Italy has raised new concerns about the nation’s ability to repay its debts, as the spread between German and Italian bonds has widened. Market instability has also spread to Spain where the nation’s parliament is preparing to vote on whether to oust Prime Minister Mariano Rajoy and his party. Oil prices slid one news that OPEC and Russia will consider hikes in production during a meeting in Vienna, Austria on June 22nd. The news accompanied reports that U.S. production is expected to rise throughout the summer. The price of WTI oil sat at $67.20 per barrel. The Brent crude oil price recovered this morning, adding 1% to hit $76.12. Canadian banks are under pressure this morning over a major breach by cyber criminals. The Bank of Montreal (NYSE: BMO) and the Canadian Imperial Bank of Commerce (NYSE: CM) – the two largest banking institutions in the country – announced that roughly 90,000 customers’ data may have been stolen. This would be the first major cybersecurity event to happen in Canada involving financial firms.
    Three Stocks to Watch Today: CRM, SBUX, MOMO
    com (NYSE: CRM) will lead a busy day of earnings reports on Wall Street. The cloud computing giant is set to report fiscal first quarter 2019 numbers after the bell on Tuesday. The average analyst projection calls for a 46% jump in EPS of $0.46 on top of a 23% gain in revenue to $2.94 billion. Starbucks’ Corporation (Nasdaq: SBUX) will temporarily close about 8,000 locations on Tuesday to train roughly 175,000 employees on racial bias. The training sessions were

  • [By Ethan Ryder]

    JA Solar (NASDAQ:JASO) is scheduled to be posting its quarterly earnings results before the market opens on Monday, July 2nd. Analysts expect JA Solar to post earnings of $0.20 per share for the quarter.

Top 10 Stocks To Buy For 2019: Tarena International, Inc.(TEDU)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Tarena International Inc. (ADR) (NASDAQ:TEDU) plummeted 22.1% on Tuesday after the China-based professional education services provider announced disappointing first-quarter 2018 results. 

  • [By Joseph Griffin]

    Schroder Investment Management Group trimmed its holdings in Tarena International Inc (NASDAQ:TEDU) by 7.9% in the second quarter, Holdings Channel reports. The fund owned 1,716,054 shares of the business services provider’s stock after selling 146,939 shares during the period. Schroder Investment Management Group’s holdings in Tarena International were worth $12,922,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Credit Suisse Group cut shares of Tarena International (NASDAQ:TEDU) from an outperform rating to a neutral rating in a report published on Thursday morning, Marketbeat reports.

Top 10 Stocks To Buy For 2019: Peapack-Gladstone Financial Corporation(PGC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Thrivent Financial for Lutherans lifted its position in shares of Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) by 16.3% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 48,531 shares of the financial services provider’s stock after purchasing an additional 6,789 shares during the quarter. Thrivent Financial for Lutherans owned about 0.26% of Peapack-Gladstone Financial Co. Common Stock worth $1,621,000 as of its most recent filing with the SEC.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Peapack-Gladstone Financial Co. Common Stock (PGC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Bank of N.T. Butterfield & Son (NYSE: NTB) and Peapack-Gladstone Financial Co. Common Stock (NASDAQ:PGC) are both finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends.

Top 10 Stocks To Buy For 2019: Evoke Pharma, Inc.(EVOK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news stories that may have impacted Accern’s rankings:

    Get Evoke Pharma alerts:

    Evoke Pharma (EVOK) Given a $9.00 Price Target by HC Wainwright Analysts (americanbankingnews.com) Evoke Pharma (EVOK) Announces FDA Acceptance of Gimoti NDA (zacks.com) FDA to Review Gimoti for Diabetic Gastroparesis in Adult Women (empr.com) Evoke Pharma’s Gimoti™ NDA Accepted for FDA Review (finance.yahoo.com)

    Shares of NASDAQ EVOK traded up $0.08 during mid-day trading on Friday, reaching $2.44. 56,399 shares of the company’s stock were exchanged, compared to its average volume of 83,661. The stock has a market cap of $42.58 million, a PE ratio of -2.94 and a beta of 1.46. Evoke Pharma has a 52-week low of $1.85 and a 52-week high of $4.09.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Evoke Pharma (EVOK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Stocks To Buy For 2019: CommVault Systems, Inc.(CVLT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CommVault Systems (CVLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    CommVault Systems, Inc. (NASDAQ:CVLT) has been assigned an average rating of “Buy” from the eleven analysts that are presently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.57.

Top 10 Stocks To Buy For 2019: BlackRock Multi-Sector Income Trust(BIT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Northwestern Mutual Wealth Management Co. increased its stake in Blackrock Multi-Sector Income Trust (NYSE:BIT) by 23.4% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 82,769 shares of the investment management company’s stock after purchasing an additional 15,675 shares during the quarter. Northwestern Mutual Wealth Management Co. owned 0.22% of Blackrock Multi-Sector Income Trust worth $1,415,000 at the end of the most recent quarter.

  • [By Shane Hupp]

    First Bitcoin (CURRENCY:BIT) traded up 12.4% against the US dollar during the one day period ending at 7:00 AM E.T. on July 1st. One First Bitcoin coin can now be bought for approximately $0.0113 or 0.00000177 BTC on major exchanges. Over the last week, First Bitcoin has traded 4% lower against the US dollar. First Bitcoin has a market capitalization of $0.00 and approximately $13.00 worth of First Bitcoin was traded on exchanges in the last day.

  • [By Max Byerly]

    BitRewards (CURRENCY:BIT) traded 7.8% lower against the US dollar during the 24-hour period ending at 19:00 PM E.T. on August 13th. One BitRewards token can now be purchased for approximately $0.0017 or 0.00000027 BTC on exchanges including IDEX and HitBTC. BitRewards has a total market capitalization of $414,691.00 and $106,200.00 worth of BitRewards was traded on exchanges in the last 24 hours. Over the last week, BitRewards has traded down 31.6% against the US dollar.

Leave a Reply

Your email address will not be published. Required fields are marked *